Turnstone Biologics

Turnstone Biologics

Company profile

About

Turnstone Biologics (NASDAQ:TSBX) is a biotechnology firm dedicated to revolutionizing cancer treatment through the development of innovative oncolytic viral immunotherapies and cancer vaccines. Leveraging cutting-edge science, Turnstone's diverse projects aim to harness the power of the body's immune system to target and destroy cancer cells, offering hope for more effective treatments with fewer side effects. The company is focused on advancing its pipeline of novel therapies through clinical trials, with the objective of achieving breakthroughs in cancer care and improving patient outcomes.

Snapshot

2014Year founded

80Employees

La Jolla, United StatesHead office

Loading Map...

Global footprint

Operations

All Locations

United States

Products and/or services of Turnstone Biologics

Viral immunotherapies leveraging Maraba virus platform for various cancers.
Development of novel oncolytic vaccines for solid tumors.
Collaboration projects for enhancing CAR-T and immune checkpoint inhibitors' efficacy.
Production of engineered viruses for precision cancer therapy.
Research on combining viral therapies with existing cancer treatments for synergy.
Services in biomanufacturing for oncolytic virus-based therapies.